Works by Yu, Olivia


Results: 13
    1
    2
    3
    4
    5
    6
    7

    Oral Azacitidine (Oral-AZA) in Patients with Acute Myeloid Leukemia (AML) in First Remission after Intensive Chemotherapy (IC): Long-Term Overall Survival (OS) Results from the Phase 3 QUAZAR AML-001 Trial.

    Published in:
    Journal of Oncology Navigation & Survivorship, 2022, v. 13, n. 11, p. 378
    By:
    • Wei, Andrew H.;
    • Döhner, Hartmut;
    • Sayar, Hamid;
    • Ravandi, Farhad;
    • Montesinos, Pau;
    • Dombret, Hervé;
    • Selleslag, Dominik;
    • Porkka, Kimmo;
    • Jun Ho Jang;
    • Skikne, Barry;
    • Beach, C. L.;
    • Tian, Yu (Olivia);
    • Roboz, Gail J.
    Publication type:
    Article
    8
    9
    10
    11
    12
    13